Isolation and structure elucidation of cystargamide, a lipopeptide from Kitasatospora cystarginea

Journal of Natural Products

Volumn 77, Issue 6, 2014, Pages 1372-1376

  Gill, Krista A ^a   Berrué, Fabrice ^a   Arens, Jennifer C ^b   Kerr, Russell G ^a,b  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^b UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 EPOXYDECANOYL FATTY ACID; 5 HYDROXYTRYPTOPHAN; CYSTARGAMIDE; FATTY ACID; LIPOPEPTIDE; UNCLASSIFIED DRUG;

ACTINOBACTERIA; ANALYTIC METHOD; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; DRUG ISOLATION; DRUG PURIFICATION; DRUG SCREENING; DRUG STRUCTURE; FERMENTATION TECHNIQUE; KITASATOSPORA CYSTARGINEA; LIPID COMPOSITION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRINCIPAL COMPONENT ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STRUCTURE ANALYSIS;

ACTINOMYCES; CANDIDA ALBICANS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENTEROCOCCUS FAECIUM; FATTY ACIDS; LIPOPEPTIDES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; VANCOMYCIN;

EID: 84903612196     PISSN: 01633864     EISSN: 15206025     Source Type: Journal    
DOI: 10.1021/np500122s     Document Type: Article

References (17)

1. Forner, D.; Berrué, F.; Correa, H.; Duncan, K.; Kerr, R. G. Anal. Chim. Acta 2013, 805, 70-79
2. Ichikawa, N.; Oguchi, A.; Ikeda, H.; Ishikawa, J.; Kitani, S.; Watanabe, Y.; Nakamura, S.; Katano, Y.; Kishi, E.; Sasagawa, M.; Ankai, A.; Fukui, S.; Hashimoto, Y.; Kamata, S.; Otoguro, M.; Tanikawa, S.; Nihira, T.; Horinouchi, S.; Ohnishi, Y.; Hayakawa, M.; Kuzuyama, T.; Arisawa, A.; Nomoto, F.; Miura, H.; Takahashi, Y.; Fujita, N. DNA Res. 2010, 17, 393-406
3. Werner, G.; Hagenmaier, H.; Drautz, H.; Baumgartner, A.; Zahner, H. J. Antibiot. 1984, 37, 110-117
4. Yoon, T. M.; Kim, J. W.; Kim, J. G.; Kim, W. G.; Suh, J. W. J. Antibiot. 2006, 59, 633-639
5. Arens, J. C.; Berrué, F.; Pearson, J. K.; Kerr, R. G. Org. Lett. 2013, 15, 3864-3867
6. Hiramoto, M.; Niwa, A.; Miyake, A.; Yamamoto, H.; Takebayashi, Y.; Nishikawa, T.; Shibazaki, M.; Nagai, K. Symposium on the Chemistry of Natural Products; Yamanouchi Pharmaceutical Co., Ltd.: Tokyo, Japan, 1993; pp 678-684.
7. Marfey, P. Carlsberg Res. Commun. 1984, 49, 591-596
8. Williamson, K. L.; Lanford, C. A.; Nicholson, C. R. J. Am. Chem. Soc. 1964, 86, 762-765
9. Strieker, M.; Marahiel, M. A. ChemBioChem 2009, 10, 607-616
10. Lakey, J. H.; Lea, E. J.; Rudd, B. A.; Wright, H. M.; Hopwood, D. A. J. Gen. Microbiol. 1983, 129, 3565-3573
11. Castiglione, F.; Marazzi, A.; Meli, M.; Colombo, G. Magn. Reson. Chem. 2005, 43, 603-10
12. Somner, E. A.; Reynolds, P. E. Antimicrob. Agents Chemother. 1990, 34, 413-419
13. Yu, H. S.; Reiter, R. J. Melatonin: Biosynthesis, Physiological Effects, and Clinical Applications; CRC Press: Boca Raton, FL, U.S.A., 1993; Chapter 1, pp 1-16.
14. Debono, M.; Bamhart, M.; Carrell, C. B.; Hoffmann, J. A.; Occolowitz, J. L.; Abbott, B. J.; Fukuda, D. S.; Hamil, R. L.; Biemann, K.; Herliby, W. C. J. Antibiot. 1987, 40, 761-777
15. Hojati, Z.; Milne, C.; Harvey, B.; Gordon, L.; Borg, M.; FioFlett, F.; Wilkinson, B.; Sidebottom, P. J.; Rudd, B. A. M.; Hayes, M. A.; Smith, C. P.; Micklefield, J. Chem. Biol. 2002, 9, 1175-1187
16. Tamamura, T.; Sawa, T.; Isshiki, K.; Masuda, T.; Homma, Y.; Iinuma, H.; Naganawa, H.; Takeuchi, T.; Umezawa, H. J. Antibiot. 1985, 38, 1664-1669
17. Ferarro, M. J. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard, 6 th ed., M7-A6. Committee for Clinical Laboratory Standards: Wayne, PA, 2003; Vol. 23 (2).